Patents by Inventor Detlef Oswald

Detlef Oswald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA constructs for specific inhibition of gene expression by RNA interference
    Patent number: 9012620
    Abstract: The invention relates to expression constructs for targeted inhibition of gene expression and methods for their production and which, after transfection thereof into eukaryotic cells, are suitable for inhibiting in a targeted manner these cells formation of defined proteins by RNA interference, wherein the method is a three step method requiring no PCR steps and is carried out in one reaction vessel in a few hours and are suitable for multiple gene expression inhibition.
    Type: Grant
    Filed: November 22, 2006
    Date of Patent: April 21, 2015
    Assignee: Mologen AG
    Inventors: Matthias Schroff, Detlef Oswald
  • Vaccine against oncovirus infections such as infections by feline leukosis virus of the cat
    Patent number: 7915035
    Abstract: The invention concerns a vaccine that can induce protection against disease especially in consequence of a lentivirus infection, especially an infection with the Feline Leukosis virus. Such vaccine comprises codon-optimized DNA sequences encoding structural proteins and the most important membrane protein of FeLV.
    Type: Grant
    Filed: September 23, 2003
    Date of Patent: March 29, 2011
    Assignee: Mologen AG
    Inventors: Claas Junghans, Matthias Schroff, Christiane Juhls, Detlef Oswald, Hans Lutz
  • Dna Constructs for Specific Inhibition of Gene Expression by Rna Interference
    Publication number: 20080311630
    Abstract: The invention relates to expression constructs for targeted inhibition of gene expression and methods for their production and which, after transfection thereof into eukaryotic cells, are suitable for inhibiting in a targeted manner these cells formation of defined proteins by RNA interference, wherein the method is a three step method requiring no PCR steps and is carried out in one reaction vessel in a few hours and are suitable for multiple gene expression inhibition.
    Type: Application
    Filed: November 22, 2006
    Publication date: December 18, 2008
    Applicant: Mologen AG
    Inventors: Matthias Schroff, Detlef Oswald